View Cart  

Roche Raises Illumina Bid to $51, Seeking Faster Deal

A A
Illumina, the U.S. maker of gene-mapping tools, rose above Roche’s increased hostile takeover bid, indicating investors are betting that an even higher offer will come.
Bloomberg